(1)
Nyambe, H.; Santoso, A.; Tabri, N. A.; Iskandar, H.; Ilyas, M.; Wiriyansyah, E. P. . The Survival Rate Comparison of Non Small Cell Lung Carcinoma Patients Who Are Given by Epidermal Growth Factor Receptor-Tyrosin Kinase Inhibitor and Those Given by First-Line Chemotherapy Treatment. NMSJ 2022, 6, 103-115.